MedPath

E-nergEYEze, a vision-specific eHealth intervention based on cognitive behavioral therapy and self-management to reduce fatigue in adults with visual impairment

Phase 3
Completed
Conditions
<tr><td>People with a visual impairment and in the experience of severe fatigue</td></tr>
Fatigue, Visual impairment, Cognitive behavioral therapy, Self-management, eHealth, Randomized controlled trial
10047518
Registration Number
NL-OMON28085
Lead Sponsor
Amsterdam University Medical Centres
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
172
Inclusion Criteria

Visually impaired (according to WHO criteria and guidelines of the low vision rehabilitation centers) adult outpatients (18+) from Dutch low vision rehabilitation organisations (i.e. Royal Dutch Visio and Bartiméus) who experience severe fatigue (CIS-score>35), have internet-access at home and are able to speak the Dutch language adequately, will be eligible to participate.

Exclusion Criteria

Exclusion criteria are: severe cognitive limitations assessed with the 6-item screener (short validated Mini Mental State Examination with a score <3), or currently receiving treatment or having received treatment in the last 12 months for another comorbid disease that clearly is the main cause of fatigue (i.e. multiple sclerosis (MS), cancer, psychiatric disorder).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Fatigue severity will be measured with the Fatigue Severity (FS) subscale of the Checklist Individual Strenghts (CIS)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Adaptation to vision loss, symptoms of depression, anxiety, vision-related quality of life, work functioning and work participation, need for recovery, sleep disorder, health care utilisation, medication use, absenteeism and presenteeism from paid and unpaid work, health-related quality of life.</p><br>
© Copyright 2025. All Rights Reserved by MedPath